SPARC completes patient enrolment for Parkinson's study, shares up
SPARC's mission is to improve patient access to affordable cures worldwide by optimising operational efficiencies and lowering costs30-10-2023
SPARC completes patient enrolment for Parkinson's study, shares up
SPARC's mission is to improve patient access to affordable cures worldwide by optimising operational efficiencies and lowering costsSUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
PRESS RELEASE : SPARC completes Enrollment in PROSEEK, A Global Phase 2 study of Vodobatinib in Early Parkinson''s DiseaseSUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Clarification To Volume Movement
Dear Sir/ Madam, Sub: clarification - Increase in Volume Ref: emailed dated 19th October, 2023 bearing ref no. L/SURV/ONL/PV/KA/2023-2024/392 With reference to above communication, we confirm that the Company is in compliance with the requirement of Regulation 30 of SEBI (LODR) 2015. We are not aware of any information which qualifies to be disclosed under the said regulation but have not been disclosed. We remain committed to make adequate and timely disclosure to the stock exchange in compliance with the applicable regulations.SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Board Meeting Intimation for Quarter And Half Year Ended September 30, 2023
SUN PHARMA ADVANCED RESEARCH COMPANY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2023 ,inter alia, to consider and approve Board Meeting IntimationSUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Clarification sought from Sun Pharma Advanced Research Company Ltd
The Exchange has sought clarification from Sun Pharma Advanced Research Company Ltd on October 19, 2023, with reference to Movement in Volume.The reply is awaited.SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release - SPARC to provide Update on Clinical Programs and R&D PipelineSUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Closure of Trading Window
Intimation for closure of trading window